Physician profile
Ben Peter Boyer
NPI 1477703338
$651.75
in general payments reported to CMS, 2019-2025
19 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.49 · 2022: $33.43 · 2023: $148 · 2024: $290 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $99.80 | 2023-2024 | |
| Amgen INC. | $82.43 | 2024 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $82.42 | 2024-2025 | Nuzyra |
| Averitas Pharma INC. | $71.61 | 2023-2025 | Qutenza |
| Horizon Therapeutics Plc | $34.35 | 2023 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $34.32 | 2025 | |
| Boston Scientific Corporation | $29.45 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Exeltis, USA INC. | $29.41 | 2024 | Slynd |
| Ani Pharmaceuticals, INC. | $25.01 | 2025 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $20.33 | 2021 | |
| Solventum Corporation | $18.71 | 2024 | Activ.A.C. |
| Qol Medical, LLC | $18.18 | 2024 | Sucraid |
| Sanofi Pasteur INC. | $16.91 | 2022 | |
| Glaxosmithkline, LLC. | $16.52 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.42 | 2023 | Jublia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.78 | 2023 | Spravato |
| Urgo Medical North America, LLC | $14.76 | 2024 | Urgok2 |
| Medtronic, INC. | $14.18 | 2025 | Inceptiv |
| Astrazeneca Pharmaceuticals LP | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Boyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.